Literature DB >> 8722494

Effects of 5-lipoxygenase inhibitors on interleukin production by human synovial tissues in organ culture: comparison with interleukin-1-synthesis inhibitors.

K D Rainsford1, C Ying, F Smith.   

Abstract

Prostaglandins and leukotrienes differentially regulate the production of interleukin-1 (IL-1) in monocytes. It was, therefore, decided to investigate the effects of some 5-lipoxygenase inhibitors compared with standard IL-1 synthesis inhibitors on the production of IL-1 by human synovial tissue explants in organ culture. Human synovial (from hip/knee arthroplasty) or porcine tibio-tarsal joint synovial explants were incubated in organ culture in Dulbecco's Modified Eagle's Medium + 5% foetal calf serum in the presence of the test compounds or solvents (controls), or media alone for 1-5 days. Total bioactive IL-1 was assayed in the medium (following serial dilution or with polyethylene glycol 8000 added in some assays to remove inhibitors) using the D-10 T-cell bioassay. Some assays of interleukins 1 alpha, 1 beta, 6 or 8 were performed by ELISA. Of the 5-lipoxygenase inhibitors investigated, MK-886(3-(1-(4-chlorobenzyl)-3-tert-butyl-thio-5-isopropylindol-2- yl)-2,2 -dimethyl propanoic acid), L-656,224 ((7-chloro-2-[4-methoxypenyl]methyl)-3 -methyl-5-propyl-4-benzofuranol), PF-5901 and tepoxalin were the most potent inhibitors of IL-1 production. While the PF-5901 was effective at 5-30 microM and tepoxalin was effective at 1-10 microM, the others were the most potent having minimal inhibitory activity in the range of 0.01-0.1 microM. The presumed IL-1-synthesis inhibitors, tenidap and IX-207,887, were inactive at concentrations of 30-50 microM. Leukotriene B4 (1-100 ng/mL-1) added to MK-886 (5 microM)-treated cultures reversed the inhibitory effects of the latter on IL-1, confirming the role of 5-lipoxygenase products in the regulation of IL-1 production. Addition of polyethylene glycol 8000 to MI-886-treated cultures eliminated the inhibitory effects of this drug, suggesting that this drug exerts its effects by promoting production of IL-1 inhibitors. MK-886 also inhibited synovial production of two other pleiotrophic cytokines which it regulates, IL-6 and IL-8. The results suggest that some 5-lipoxygenase inhibitors may be usefully employed in regulating production of those interleukins involved in joint cartilage destruction.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8722494     DOI: 10.1111/j.2042-7158.1996.tb05875.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  14 in total

1.  Chemopreventive efficacy and mechanism of licofelone in a mouse lung tumor model via aspiration.

Authors:  Sheela Sharma; Jin Lee; Jianliang Zhou; Vernon E Steele
Journal:  Cancer Prev Res (Phila)       Date:  2011-05-11

2.  Lipoxygenase and Cyclooxygenase Pathways and Colorectal Cancer Prevention.

Authors:  Chinthalapally V Rao; Naveena B Janakiram; Altaf Mohammed
Journal:  Curr Colorectal Cancer Rep       Date:  2012-12

Review 3.  Combined lipoxygenase/cyclo-oxygenase inhibition in the elderly: the example of licofelone.

Authors:  Arrigo F G Cicero; Giuseppe Derosa; Antonio Gaddi
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

4.  The regulation of human MMP-13 by licofelone, an inhibitor of cyclo-oxygenases and 5-lipoxygenase, in human osteoarthritic chondrocytes is mediated by the inhibition of the p38 MAP kinase signalling pathway.

Authors:  C Boileau; J-P Pelletier; G Tardif; H Fahmi; S Laufer; M Lavigne; J Martel-Pelletier
Journal:  Ann Rheum Dis       Date:  2004-10-21       Impact factor: 19.103

Review 5.  The analgesic potential of glycosides derived from medicinal plants.

Authors:  Haroon Khan; Aini Pervaiz; Sebastiano Intagliata; Niranjan Das; Kalyan C Nagulapalli Venkata; Atanas G Atanasov; Agnieszka Najda; Seyed Mohammad Nabavi; Dongdong Wang; Valeria Pittalà; Anupam Bishayee
Journal:  Daru       Date:  2020-02-14       Impact factor: 3.117

Review 6.  Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs.

Authors:  J Martel-Pelletier; D Lajeunesse; P Reboul; J-P Pelletier
Journal:  Ann Rheum Dis       Date:  2003-06       Impact factor: 19.103

7.  Simultaneous targeting of 5-LOX-COX and ODC block NNK-induced lung adenoma progression to adenocarcinoma in A/J mice.

Authors:  Gaurav Kumar; Jagan Mohan R Patlolla; Venkateshwar Madka; Altaf Mohammed; Qian Li; Yuting Zhang; Laura Biddick; Anil Singh; Allison Gillaspy; Stanley Lightfoot; Vernon E Steele; Levy Kopelovich; Chinthalapally V Rao
Journal:  Am J Cancer Res       Date:  2016-05-01       Impact factor: 6.166

Review 8.  The role of 5-lipoxygenase in the pathophysiology of COVID-19 and its therapeutic implications.

Authors:  Nohora Cristina Ayola-Serrano; Namrata Roy; Zareena Fathah; Mohammed Moustapha Anwar; Bivek Singh; Nour Ammar; Ranjit Sah; Areej Elba; Rawan Sobhi Utt; Samuel Pecho-Silva; Alfonso J Rodriguez-Morales; Kuldeep Dhama; Sadeq Quraishi
Journal:  Inflamm Res       Date:  2021-06-04       Impact factor: 6.986

9.  An exploration of the ability of tepoxalin to ameliorate the degradation of articular cartilage in a canine in vitro model.

Authors:  Lisa Macrory; Anne Vaughan-Thomas; Peter D Clegg; John F Innes
Journal:  BMC Vet Res       Date:  2009-07-22       Impact factor: 2.741

Review 10.  Activity and potential role of licofelone in the management of osteoarthritis.

Authors:  Arrigo F G Cicero; Luca Laghi
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.